Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
04/2011
04/06/2011EP1966127B1 Carbonyl asymmetric alkylation
04/06/2011EP1836149B1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
04/06/2011EP1404324B2 Prodrugs of gaba analogs, compositions and uses thereof
04/06/2011EP1303479B1 7-, 8- and 9-substituted tetracycline compounds
04/06/2011CN1946680B 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
04/06/2011CN1376146B Solid-state form of celecoxil having enhanced bioavailability
04/06/2011CN102007100A Compounds and compositions as modulators of GPR119 activity
04/06/2011CN102002026A Preparation method of benzofuran-2-(3H)-ketone
04/06/2011CN102002025A Acetylation modifying method of resveratrol dipolymer
04/06/2011CN102002024A 3-aryl-4-arylamino-2 (5(i)H(/i))-furanone compounds as well as preparation method and application thereof
04/06/2011CN102001916A 作为药物活性剂的茚衍生物 Indene derivatives as pharmaceutically active agent
04/06/2011CN102000606A Chiral ruthenium catalyst and use thereof in asymmetric hydrogenation of ketone
04/06/2011CN102000595A Preparation method of organic phase of vanadium-phosphorus-oxide catalysts and application thereof in preparing maleic anhydride by using furfuraldehyde
04/06/2011CN102000569A Catalyst for producing furan by furfural liquid-phase decarbonylation and preparation method
04/06/2011CN101402626B Reutilization method for low pressure by-product steam in benzoic anhydride producing process
04/06/2011CN101353337B Vitamin c clean production method
04/06/2011CN101270073B Biphenyl compound with dissymmetrical structure, preparation method and application thereof
04/06/2011CN101095720B Method for preparing total salvianolic acid and the application in the preventing and treating of diabetes and the complication thereof
04/06/2011CN101068796B Compounds, compositions and thin films
04/06/2011CN101056861B Carbamoyl-substituted spiro derivative
04/05/2011US7919599 Production of L-iduronate containing polysaccharides
04/05/2011US7919529 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
04/05/2011US7919528 Antibiotic; bactericides
04/05/2011US7919523 Inhibitors of aspartyl protease
04/05/2011US7919519 1-(4-(5-Phenylbenzofuran-2-yl)benzyl)azetidine-3-carboxylic acids; anticarcinogenic, antiinflammatory, antiarthritic, antidiabetic agents; transplant rejection, autoimmune diseases, lupus, multiple sclerosis, psoriasis, inflammatory bowel disease, Chron's disease
04/05/2011CA2475434C Aromatic amino acid derivatives and medicinal compositions
03/2011
03/31/2011WO2011037192A1 Substituted amide compound
03/31/2011WO2011035445A1 Heterogeneous rhodium metal catalysts
03/31/2011WO2010132740A3 Oxidation of furfural compounds
03/31/2011WO2010131844A3 Method for producing biofuel using marine algae-derived galactan
03/31/2011US20110077416 Compound comprising triarylamine moieties and a condensed ring moiety, and the production method thereof
03/31/2011US20110077295 Andrographolide derivatives and use thereof in manufacture of medicaments
03/31/2011CA2775308A1 Heterogeneous rhodium metal catalysts
03/31/2011CA2774647A1 Substituted amide compound
03/30/2011EP2301926A1 Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound
03/30/2011EP2301914A1 7,9-Substituted tetracycline compounds
03/30/2011EP2301913A1 7,9-Substituted tetracycline compounds
03/30/2011EP2301540A1 A therapeutic agent for impaired gastric accomodation
03/30/2011EP2301534A1 Amino-methyl substituted tetracycline compounds
03/30/2011EP2300572A1 Fuel composition
03/30/2011EP2300448A1 Process for the hydrogenolysis of furfuryl derivatives
03/30/2011EP1742927B1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
03/30/2011EP1178026B1 Processes for producing oxide with higher oxidation than alcohol
03/30/2011EP0933354B1 Calcium receptor-active compounds
03/30/2011CN201776145U Anhydride forming kettle
03/30/2011CN1976710B Compounds and compositions as cathepsin S inhibitors
03/30/2011CN101998852A Novel estrogen receptor ligands
03/30/2011CN101993427A New method for preparing Dronedarone
03/30/2011CN101993426A 3-aryl glutaric acid mono-amide compound as well as preparation method and application thereof
03/30/2011CN101993425A Preparation method of alpha-ethyl furan carbinol
03/30/2011CN101993424A Lariciresinol and derivative, preparation method and application thereof
03/29/2011US7915430 Catalytic method for producing phenolphthalein compounds
03/29/2011US7915429 Compounds for the treatment of metabolic disorders
03/29/2011US7915413 Compounds
03/29/2011US7915300 Cysteine protease inhibitors
03/29/2011US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases
03/29/2011US7915282 Preparation by intramolecular cyclization
03/29/2011US7914700 Liquid crystal compositions and polymer networks derived therefrom
03/29/2011CA2641877C Improved process for producing nitroguanidine derivatives
03/29/2011CA2474208C Astaxanthin esters
03/24/2011WO2011034118A1 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and oriented film
03/24/2011WO2010091384A3 Cadherin-11 inhibitors and methods of use thereof
03/24/2011US20110071306 Biomass refining by selective chemical reactions
03/24/2011US20110071095 Compositions and Methods for Increasing Telomerase Activity
03/24/2011US20110068683 Anthracene derivatives, luminescent materials and organic electroluminescent devices
03/23/2011EP2298732A1 7,9-Substituted tetracycline compounds
03/23/2011EP2298311A1 w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
03/23/2011EP2297272A1 Dibenzofurane polymers for electroluminiscent devices
03/23/2011EP1846353B1 Method for controlling hydrogenation
03/23/2011CN101990535A Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
03/23/2011CN101987840A Method for separating 5-hydroxy-4-methyl-2-5[H]-furanone
03/23/2011CN101987839A Method for preparing 2,5-diformylfuran by oxidizing 5-hydroxymethylfurfural
03/23/2011CN101544625B Ultrasonic extraction method for salvianolic acid B
03/23/2011CN101434590B Preparation of salvianolic acid B pure product
03/23/2011CN101402649B Fatty acid aluminium isopropoxide, preparation method and application thereof
03/23/2011CN101283998B Application of bromine phenolic compound in preparing the medicine for curing the malignancy
03/22/2011US7910775 Synthesis of 2-Hydroxy-N,N-dimethyl-3-[[2-[[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide
03/22/2011US7910774 Alternative synthesis of renin inhibitors and intermediates thereof
03/22/2011US7910762 mixing a pentavalent niobium compound and a tetraol having an optically active binapthol; catalysts for the following asymmetric reactions: Mannich, epoxide ring opening, allylation, cyanation, and alkylation; reacting silicon enolate with imine to form beta-aminocarbonyl compound
03/22/2011US7910752 Anticancer compound, intermediate therefor, and processes for producing these
03/22/2011US7910749 with oxygen in the presence of a catalyst, in which the catalyst contains a N-hydroxy- or N-(substituted oxy)-imide compound derivable from at least one selected from a target product, a reaction intermediate, and a reaction byproduct
03/22/2011US7910622 Modulation of bacterial quorum sensing with synthetic ligands
03/17/2011WO2011031023A2 Method for producing cyclicised compounds from organic acids having from 4 to 6 carbon atoms
03/17/2011WO2011030881A1 Furan derivative and electrophotographic photoconductor
03/17/2011US20110065938 Method for the preparation of escitalopram
03/17/2011US20110065937 Method for the separation of intermediates which may be used for the preparation of escitalopram
03/17/2011US20110065929 Homogeneous asymmetric hydrogenation catalyst
03/17/2011US20110065786 Synthesis of rocaglamide natural products via photochemical generation of oxidopyrylium species
03/17/2011US20110065760 Compounds for the inhibition of rotamases and use thereof
03/17/2011US20110065710 Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives
03/16/2011EP2295421A1 Aromatic amine derivative and organic electroluminescent device using the same
03/16/2011EP2295420A1 Carbonylamino fulvene compounds and their use as ligands of nickel based catalysts for the production of isotactic polystyrene
03/16/2011EP2295406A1 Heterocyclic compound
03/16/2011EP2295404A2 Substituted tetracycline compounds
03/16/2011EP2295402A2 Antibacterial agents
03/16/2011EP2295052A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450
03/16/2011EP2294060A1 Process for separating off fumaric acid and other minor components during the production of maleic anhydride
03/16/2011CN201764853U Pre-condenser
03/16/2011CN201760284U Rotary spherical digester for production of furfural
03/16/2011CN201760282U High-efficiency hydrolysis kettle
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 472